US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 3.890
  • +0.370+10.51%
Close Dec 26 16:00 ET
  • 3.880
  • -0.010-0.26%
Post 20:01 ET
2.71MMarket Cap-0.14P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.60%-3.91M
46.72%-2.34M
12.77%-3.94M
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
Net income from continuing operations
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Depreciation and amortization
-8.11%127.52K
3.81%142.83K
41.37%141.65K
424.05%516.75K
375.08%140.17K
459.56%138.78K
506.18%137.59K
363.86%100.2K
132.18%98.61K
1.78%29.51K
Change In working capital
-252.27%-1.92M
530.88%1.56M
-2,205.20%-935.21K
-182.69%-1.08M
-312.35%-2.03M
580.57%1.26M
-130.83%-363.12K
107.92%44.42K
179.56%1.31M
-15.36%954.27K
-Change in receivables
---11.95K
--0
--0
200.00%360.23K
--0
--0
--0
--360.23K
---360.23K
--127.65K
-Change in prepaid assets
-15.48%-692.9K
-45.25%768.48K
83.29%-112.5K
351.25%362.91K
-3.35%232.64K
67.46%-600.02K
5.18%1.4M
-641.83%-673.21K
92.41%-144.44K
-69.84%240.71K
-Change in payables and accrued expense
-158.37%-1.14M
152.10%908.3K
-218.84%-684.49K
-170.29%-1.3M
-442.55%-2.09M
-3.69%1.96M
-1,329.90%-1.74M
184.96%575.98K
-21.23%1.84M
17.45%609.45K
-Change in other current assets
--0
--0
--0
---111.86K
--0
--0
--0
---111.86K
--0
--0
-Change in other current liabilities
-8.99%-74.77K
-6.88%-112.16K
-4.16%-111.16K
---424.39K
---144.12K
---68.6K
---104.94K
---106.72K
--0
--0
-Change in other working capital
--0
--0
---27.06K
188.63%27.06K
-15.77%-27.25K
---27.44K
----
----
-200.00%-30.53K
87.58%-23.54K
Cash from discontinued investing activities
Operating cash flow
-11.60%-3.91M
46.72%-2.34M
12.77%-3.94M
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
Investing cash flow
Cash flow from continuing investing activities
-179.42%-12.87K
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
0
-4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
Net PPE purchase and sale
-179.42%-12.87K
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
Cash from discontinued investing activities
Investing cash flow
-179.42%-12.87K
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
Financing cash flow
Cash flow from continuing financing activities
-66.89%2.45M
-87.65%785.2K
415.56%6.09M
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
Net common stock issuance
-66.27%2.45M
-87.91%785.2K
415.56%6.09M
--15.91M
--978.15K
--7.26M
--6.5M
--1.18M
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-79.54%5.99K
--0
Cash from discontinued financing activities
Financing cash flow
-66.89%2.45M
-87.65%785.2K
415.56%6.09M
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
--6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
Net cash flow
Beginning cash position
-6.10%3.35M
202.82%4.91M
-44.30%2.77M
-76.14%4.97M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
2,415.15%20.83M
-60.93%8.79M
Current changes in cash
-138.11%-1.48M
-179.96%-1.56M
164.14%2.15M
86.12%-2.2M
-22.58%-4.69M
183.49%3.88M
157.11%1.95M
15.79%-3.35M
-179.30%-15.86M
-128.32%-3.82M
End cash Position
-74.83%1.88M
-6.10%3.35M
202.82%4.91M
-44.30%2.77M
-44.30%2.77M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
-76.14%4.97M
Free cash flow
-11.82%-3.93M
46.84%-2.34M
12.93%-3.94M
-14.16%-18.11M
-39.91%-5.66M
20.62%-3.51M
-29.16%-4.41M
-13.75%-4.53M
-187.29%-15.86M
-140.02%-4.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.60%-3.91M46.72%-2.34M12.77%-3.94M-14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M
Net income from continuing operations 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Depreciation and amortization -8.11%127.52K3.81%142.83K41.37%141.65K424.05%516.75K375.08%140.17K459.56%138.78K506.18%137.59K363.86%100.2K132.18%98.61K1.78%29.51K
Change In working capital -252.27%-1.92M530.88%1.56M-2,205.20%-935.21K-182.69%-1.08M-312.35%-2.03M580.57%1.26M-130.83%-363.12K107.92%44.42K179.56%1.31M-15.36%954.27K
-Change in receivables ---11.95K--0--0200.00%360.23K--0--0--0--360.23K---360.23K--127.65K
-Change in prepaid assets -15.48%-692.9K-45.25%768.48K83.29%-112.5K351.25%362.91K-3.35%232.64K67.46%-600.02K5.18%1.4M-641.83%-673.21K92.41%-144.44K-69.84%240.71K
-Change in payables and accrued expense -158.37%-1.14M152.10%908.3K-218.84%-684.49K-170.29%-1.3M-442.55%-2.09M-3.69%1.96M-1,329.90%-1.74M184.96%575.98K-21.23%1.84M17.45%609.45K
-Change in other current assets --0--0--0---111.86K--0--0--0---111.86K--0--0
-Change in other current liabilities -8.99%-74.77K-6.88%-112.16K-4.16%-111.16K---424.39K---144.12K---68.6K---104.94K---106.72K--0--0
-Change in other working capital --0--0---27.06K188.63%27.06K-15.77%-27.25K---27.44K---------200.00%-30.53K87.58%-23.54K
Cash from discontinued investing activities
Operating cash flow -11.60%-3.91M46.72%-2.34M12.77%-3.94M-14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M
Investing cash flow
Cash flow from continuing investing activities -179.42%-12.87K74.84%-4.56K70.25%-3.84K64.72%-35.61K0-4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K
Net PPE purchase and sale -179.42%-12.87K74.84%-4.56K70.25%-3.84K64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K
Cash from discontinued investing activities
Investing cash flow -179.42%-12.87K74.84%-4.56K70.25%-3.84K64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K
Financing cash flow
Cash flow from continuing financing activities -66.89%2.45M-87.65%785.2K415.56%6.09M265,542.41%15.91M333.16%978.15K3,372.94%7.39M6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K
Net common stock issuance -66.27%2.45M-87.91%785.2K415.56%6.09M--15.91M--978.15K--7.26M--6.5M--1.18M--0--0
Proceeds from stock option exercised by employees --------------0-----------------79.54%5.99K--0
Cash from discontinued financing activities
Financing cash flow -66.89%2.45M-87.65%785.2K415.56%6.09M265,542.41%15.91M333.16%978.15K3,372.94%7.39M--6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K
Net cash flow
Beginning cash position -6.10%3.35M202.82%4.91M-44.30%2.77M-76.14%4.97M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M2,415.15%20.83M-60.93%8.79M
Current changes in cash -138.11%-1.48M-179.96%-1.56M164.14%2.15M86.12%-2.2M-22.58%-4.69M183.49%3.88M157.11%1.95M15.79%-3.35M-179.30%-15.86M-128.32%-3.82M
End cash Position -74.83%1.88M-6.10%3.35M202.82%4.91M-44.30%2.77M-44.30%2.77M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M-76.14%4.97M
Free cash flow -11.82%-3.93M46.84%-2.34M12.93%-3.94M-14.16%-18.11M-39.91%-5.66M20.62%-3.51M-29.16%-4.41M-13.75%-4.53M-187.29%-15.86M-140.02%-4.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Adobe
ADBE
+0.50%
Lennar Corp
LEN
+0.46%
Petroleo Brasileiro SA Petrobras
PBR
+0.46%
Apple
AAPL
+0.32%
D.R. Horton
DHI
+0.30%

Unlock the Full List